Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
SOM Biotech, a biopharmaceutical company specializing in the repositioning of existing drugs for the treatment of diseases with a high unmet need,...
SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for ...
SOM Biotech, a clinical-stage drug discovery and development company focused on orphan diseases, closes a remarkable year, achieving relevant...
SOM Biotech, a clinical-stage drug discovery and development company focused on repurposing drugs for orphan diseases of the Central Nervous System...
SOM Biotech, a clinical-stage biopharmaceutical company that discovers and develops drugs for orphan indications in the Central Nervous System, has...
SOM Biotech (SOM), a leading drug repurposing company based in Barcelona, Spain, has determined and validated an entirely new usage for Nippon...
The med-tech biopharmaceutical company SOM Biotech, specializing in repurposing drugs to treat rare nervous system diseases, has concluded a...
SOM Biotech, with headquarters located at the Barcelona Science Park (PCB), is announcing its very first crowdfunding campaign for the purpose of...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.